A naturally occurring mutation in FcγRIIA: A Q to K127 change confers unique IgG binding properties to the R131 allelic form of the receptor

Blood

Volumn 91, Issue 2, 1998, Pages 656-662

  Norris, Cynthia F ^a   Pricop, Luminita ^b   Millard, Sean S ^b   Taylor, Scott M ^b   Surrey, Saul ^b   Schwartz, Elias ^b   Salmon, Jane E ^b   McKenzie, Steven E ^b,c  

^a NIH T32 HL07150

^b R01 DK16691 ^*

^c NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR;

AMINO ACID SUBSTITUTION; ARTICLE; CELL SURFACE; CODON; DISEASE PREDISPOSITION; GENE MUTATION; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN CELL; OPSONIZATION; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; RECEPTOR BINDING; SEQUENCE ANALYSIS; THROMBOCYTE AGGREGATION;

EID: 0031983254     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.2.656.656_656_662     Document Type: Article

References (47)

1. Abo T, Tilden AB, Balch CM, Kumagai K, Troup GM, Cooper MD: Ethnic differences in the lymphocyte proliferative response induced by a murine IgG1 antibody, Leu-4, to the T3 molecule, J Exp Med 160:303, 1984
2. Reilly AF, Morris CF, Surrey S, Bruchak FJ, Rappaport FJ, Schwartz E, McKenzie SE: Genetic diversity human Fc receptor II for immunoglobulin G: Fcγ receptor IIA ligand-binding polymorphism. Clin Diag Lab Immunol 1:640, 1994
3. Osbome JM, Chacko GW, Brandt JT, Andersen CL: Ethnic variation in frequency of an allelic polymorphism of human FcγRIIA determined with allele specific oligonucleotide probes. J Immunol Methods 173:207, 1994
4. 2 binding. J Immunol 147:1338, 1991
5. Salmon JE, Edberg JC, Brogle NL, Kimberly RP: Allelic polymorphisms of human Fcγ receptor IIA and Fcγ receptor IIIB. Independent mechanisms for differences in human phagocyte function. J Clin Invest 89:1274, 1992
6. 2. J Clin Invest 90:1537, 1992
7. 2 anti-CD3. J Immunol 148:695, 1992
8. Fijen CAP, Bredius RGM, Kuijper EJ: Polymorphism of IgG Fc receptors in meningococcal disease. Ann Intern Med 119:636, 1993
9. Bredius RG, Derkx BH, Fijen CA, de Wit TP, de Haas M, Weening RS, van de Winkel JG, Out TA: Fcγ receptor IIa (CD32) polymorphism in fulminant meningococcal septic shock in children. J Infect Dis 170:848, 1994
10. Sanders LA, van de Winkel JG, Rijkers GT, Voorhorst-Ogink MM, de Haas M, Capel PJ, Zegers BJ: Fcγ receptor IIa (CD32) heterogeneity in patients with recurrent bacterial respiratory tract infections. J Infect Dis 170:854, 1994
11. Duits AJ, Bootsma H, Derksen R, Spronk PE, Kater L, Kallenberg C, Capel PJ, Westerdaal NJ, Spoerenburg GT, Gmelig-Meyling FH, van de Winkel JG: Skewed distribution of IgG Fc receptor IIa (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patients. Arthritis Rheum 39:1832, 1995
12. Salmon JE, Millard S, Schachter LA, Arnett FC, Ginzler EM, Gourley MF, Ramsey-Goldman R, Peterson MG, Kimberly RP: FcγRIIA alleles are heritable risk factors for lupus nephritis in African Americans. J Clin Invest 97:1348, 1996
13. Burgess JK, Lindeman R, Chesterman CN, Chong BH: Single amino acid mutation of Fcγ receptor is associated with the development of heparin-induced thrombocytopenia. Br J Haematol 91:761, 1995
14. Brandt JT, Isenhart CE, Osborne JM, Ahmend A, Anderson CL: On the role of platelet FcγRIIa phenotype in heparin-induced thrombocytopenia. Thromb Haemost 74:1564, 1995
15. 1 monoclonal antibodies against T3 antigen on human T cells. Nature 304:445, 1983
16. Haagen IA, Geerars AJ, Clark MR, van de Winkel JG: Interaction of human monocyte Fc gamma receptors with rat IgG2b. A new indicator for the Fc gamma RIIa (R-H131) polymorphism. J Immunol 154:1852, 1995
17. Wee SL, Colvin RB, Phelan JM, Preffer FI, Reichert TA, Berd D, Cosimi AB: Fc-Receptor for mouse IgG1 (FcγRII) and antibody-mediated cell clearance in patients treated with Leu2a antibody. Transplantation 48:1012, 1989
18. Norris CF, Surrey S, Bunin G, Schwanz E, Buchanan G, McKenzie SE: Relationship between Fc receptor IIA polymorphism and infection in children with sickle cell disease. J Pediatr 128:813, 1996
19. Salmon JE, Millard SS, Brogle NL, Kimberly RP: Fcγ receptor IIIb enhances Fcγ receptor IIa function in an oxidant-dependent and allele-sensitive manner. J Clin Invest 95:2877, 1995
20. Gosselin EJ, Brown MF, Anderson CL, Zipf TF, Guyre PM: The monoclonal antibody 41H16 detects the Leu 4 responder form of human FcγRII. J Immunol 144:1817, 1990
21. van Amersfoot ES, van Strijp JAG: Evaluation of a flow cytometric fluorescence quenching assay of phagocytosis of sensitized sheep erythrocytes by polymorphonuclear leukocytes. Cytometry 17: 294,1994
22. 21a. Pricop L, Salmon JE, Edberg JC, Beans AJ: Flow cytometric quantitation of phagocytosis in phenotypically defined subpopulations of cells using PKH-26 labeled, FcR-specific probes. J Immunol Methods 205:55, 1997
23. Hogarth PM, Hulett MD, Ierino FL, Tate B, Powell MS, Brinkworth RI: Identification of the immunoglobulin binding regions (IBR) of FcγRII and Fe∈ RI. Immunol Rev 125:21, 1992
24. Hulett MD, Witort E, Brinkworth RI, McKenzie IFC, Hogarth PM: Identification of the IgG binding site of the human low affinity receptor for IgG FcγRII. J Biol Chem 269:15287, 1994
25. Cassel DL, Keller MA, Surrey S, Schwartz E, Schreiber AD, Rappaport EF, McKenzie SE: Differential expression of FcγRIIA, FcγRIIB and FcγRIIC in hematopoietic cells: Analysis of transcripts. Mol Immunol 30:451, 1993
26. Markovic B, Wu Z, Chesterman CN, Chong BH: Quanutitation of soluble and membrane-bound FcγRIIA (CD32) mRNA in platelets and megakaryoblastic cell line (Meg-01). Br J Haematol 91:37, 1996
27. Chacko GW, Duchemin AM, Coggeshal KM, Osborne JM, Brandt JT, Anderson CL: Clustering of the platelet Fcγ receptor induces noncovalent association with the ryrosine kinase p72syk. J Biol Chem 269:32435, 1994
28. Tomiyama Y, Kunicki TJ, Zipf TF, Ford SB, Aster RH: Response of human platelets to activating monoclonal antibodies: Importance of FcγRII (CD32) phenotype and level of expression. Blood 80:2261, 1992
29. De Reys S, Blom C, Lepoudre B, Declerck PJ, De Ley M, Vermylen J, Deckmyn H: Human platelet aggregation by murine monoclonal antiplatelet antibodies is subtype-dependent. Blood 81: 1792, 1993
30. Hogarth PM, Witort E, Hulett MD, Bonnerot C, Even J, Fridman WH, McKenzie IFC: Structure of the mouse βFcγ receptor II gene. J Immunol 146:369, 1991
31. Bocek P, Pecht I: Cloning and sequencing of the cDNA coding for rat type II Fcγ receptor of mast cells. FEBS Lett 331:86, 1993
32. Zhang G, Young JR, Tregaskes CR, Howard CJ: Cattle FcγRII: Molecular cloning and ligand specificity. Immunogenetics 39:423, 1994
33. Wang J, Yan Y, Garrett TP, Liu J, Rodgers DW, Garlick RL, Tarr GE, Husain Y, Reinherz EL, Harrison SC: Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains. Nature 348:411, 1990
34. Ryu SE, Kwong PD, Truneh A, Porter TG, Arthos J, Rosenberg M, Dai X, Xuong N, Axel R, Sweet RW, Hendrickson WA: Crystal structure of an HIV-binding recombinant fragment of human CD4. Nature 348:419, 1990
35. Jones EY, Davis SJ, Williams AF, Harlos K, Stuart DI: Crystal structure at 2.8 resolution of a soluble form of the cell adhesion molecule CD2. Nature 360:232, 1992
36. Kimberly RP, Salmon JE, Edberg JC: Receptors for Immunoglobulin G. Arthritis Rheum 38:306, 1995
37. McKenzie SE, Schreiber AD: Biological advances and clinical applications of Fc receptors for IgG. Curr Opin Hematol 1:45, 1994
38. van de Winkel JG, Capel PJ: Human IgG Fc receptor heterogeneity : Molecular aspects and clinical implications. Immunol Today 14:215, 1993
39. Reilly AF, Surrey S, Rappaport EF, Schwartz E, McKenzie SE: Variation in human FCGR2C gene copy number. Immunogenetics 40:456, 1994
40. de Haas M, Kleijer M, van Zwieten R, Roos D, von dem Borne AE: Neutrophil FcγRIIIb deficiency, nature, and clinical consequences: A study of 21 individuals from 14 families. Blood 86:2403, 1995
41. Huizinga TW, Kuijjpers RW, Kleijer M, Schulpen TW, Cuijpers HT, Roos D, von dem Borne AE: Maternal neutrophil FcγRIII deficiency leading to neonatal isoimmune neutropenia. Blood 76:1927, 1990
42. Fromont P, Bettelieb A, Skouri H, Floch C, Puolet E, Duedari N, Bierling P: Frequency of the polymorphonuclear neutrophil FcγRIII deficiency in the French population and its involvement in the development of neonatal alloimmune neutropenia. Blood 79:2131, 1992
43. Clark MR, Liu L, Clarkson SB, Ory PA, Goldstein IM: An abnormality of the gene that encodes neutrophil Fc receptor III in a patient with systemic lupus erythematosus. J Clin Invest 86:341, 1990
44. Ceuppens JL, Baroja ML, Van Vaeck F, Anderson CL: A defect in the membrane expression of high affinity 72 kd Fcγ receptors on phagocytic cells in four healthy subjects. J Clin Invest 82:571, 1988
45. van de Winkel JG, de Wit TP, Ernst LK, Capel PJ, Ceuppens JL: Molecular basis for a familial defect in expression of IgG receptor I (CD64). J Immunol 154:2896, 1995
46. 131 ligand-binding polymorphism using an allele-specific restriction enzyme digestion (ASRED), J Immunol Methods 199:55, 1996
47. Bachelot C, Saffroy R, Gandrille S, Aiach M, Rendu F: Role of FcγRIIA gene polymorphism in human platelet activation by monoclonal antibodies. Thromb Haemost 74:1557, 1995